pagiantmetknicksfan@yahoo.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agreed, that was never really a long term issue. No one doubts efficacy anyway. But it does mean that Elite went from the slow cooker to the microwave....ironically which is how you defeat Purdues product...
The FDA has never seen a product like Elite's before. The Zohydro example is by far the closest we have seen. Adding the extra bead which doesn't react unless tampered with....exactly the same concept...
You can believe the 505B2 expert and Elite's CEO who are in contact with the FDA or you can believe misinformation at this point.
That article if it is the one I think you are referring was written something like a month or two before the stock ran. The other stuff should be easy to link. No one has...lets see these links that moved the stock from .20 to .97...
I can show you probably 20 Hotstocked articles.
I guess Hysinga wasn't either. I never understood why one would be needed. Nothing is happening to the Naltrexone bead. No chemical process, no dissolving, nothing at all. They can test this all day long in the blood results. The company and Camargo has talked to the FDA all along.....why would they misinform?
Elite's products are show bioequivalance. The three drugs already show that from the various trials. I am sure some misinformation will be presented about combination products and other nonsense but the similarities between reformulated Zohydro and Eli 200 is pretty obvious. The most important thing is that the Naltrexone bead passes through undissolved which it has been proven...
That is one of the stated reasons for 505B2 is use of the previously completed efficacy and safety studies. That is the point of Camargo.
Basically Elite is on a rapid path here.
There hasn't been anything to really scare investors over outside of price manipulation. All the old stuff is gone. Even efficacy which if needed would still be fine, but that doesn't even look like that is going to be needed. It never made sense to me anyway why it would be needed and the company who actually talk to the FDA don't believe anything substantial is going to be needed. Thus claims of efficacy being needed are unsubstantiated in light of Zogenix
So what are we left with? Accusations without links that generally don't even have anything to do with the company or company's future outlook.
No one is talking about the next drug launch due or trials underway with results expected now or the next financial report which should be good...I could go on and on really.
Again...see no data presented. You would think it would be easy if it created a run to .97....Of course they don't exist.
Now what does exist? Well we have plenty of false negative misinformation all over. Hotstocked has written about 10:1 articles compared to seeking alpha. The most recent don't even examine anything about what the company is actually doing, trials, drug launches, NDA filings etc...
You have BMAK clearly manipulating for months now.
Hmmmm
On one hand you have accusations against one SA article without links and on the other you have a mountain of information
See you asked for links, and none could be presented. People claim the SA was somehow proven incorrect but they have presented nothing to that effect. Like I said it really just read like a recap of the past year. I wonder where those links are that are supposed to prove the article incorrect hiding?
People claimed the run to .97 was a P&D but there was no pump. Ask for a link and see if you get one...you won't
These people have more patience then your average OTC investor or trader. They probably have known that based on current events, not only will Elite be filing an NDA shortly but possibly multiple NDAs.
Based on how things are going in the Abuse Resistant Market, they will manipulate it down and then push the stock way up when they feel. The stock ran to .97. Some claimed P&D but there was no pump anyone could point to.
There were obvious attempts by manipulators to attack the article in the comments section but I didn't read any attack that actually addressed the facts in the article. I haven't read anything here either. The article seemed like much more of a summation of what has occurred over the past year or so,
I read that the publisher for Hotstocked that comes on and advertises for hotstocked products doesn't actually exist. He is like a fictional character. I google searched it and found the same.
Well yeah it has been obvious for awhile. Thus the misinformation out there 24/7/365...Hotstocked should be due another article today or tomorrow.
So you have this manipulation on low volume. I feel bad for people that miss the run when the stock starts to reach an appropriate value
Those claims will always exist as long as there is manipulation. Pretty obvious watching level 2 that the source of the misinformation like LOL LOL Hotstocked etc is likely working with/through BMAK and is now covering a short position
They may not have too based on the current timelines and possibilities right now. I suspect they will to clean things up but by then it will not matter. To be honest, even doing so now would probably not matter much but no need.
If anyone is claiming a stock split, they must be claiming something like a big pharma partnership or significant drug filing etc....Is that what is being claimed because these things are very close now.
However what we are seeing is the likelihood of many submissions so the growth to an acceptable stock price without a split becomes more likely
Not sure I follow. If you are saying they need full blown efficacy trials, I think that is silly at this point. If you are saying they need PK studies or two to give further confidence that Naltrexone did not leak, then I would agree
Any claims that Nasrat made a promise would have had to miss every conference call. Anyone wanting to read the truth just check out the transcripts. In fact he obviously did not promise since he noted they had to clear it with the FDA
When coupled with Elite's statements about discussions with the FDA and what has occurred with Zogenix, it makes perfect sense. I remember when the claim was that no product was ever approved without the efficacy when 505B2 uses the reference efficacy....
Those that have done the research understand this. I believe that the biggest stock manipulators using MM BMAK and outlets to spew nonsense like Hotstocked are likely huge stock holders. Or they wouldn't spend so much time on the company.
Actually it is becoming clear that they don't want efficacy studies but small PK type studies.
Who can help it if known stock manipulators using BMAK as their MM use places like Hotstocked and other outlets to disseminate false information?
WHat and which promises?
People have been trying to discredit Nasrat from the beginning. It is kind of sad because based on my research, he is pretty unique in his integrity and ability. However, the obvious manipulation seeks to extract money from those that don't see what is going on here. It is looking like significant filing news may be closer then folks realize.
That is obviously misinformation. Not sure why you are posting that since the direct quotes have been posted here a number of times....But I do agree that is is about to be filed and that is the PR stock manipulators are focused on
No but there are likely studies going on right now similar to what ZOgenix required for their reformulation. They never press released these either.
Obviously. Nasrat has noted that in pretty much every conference call. It claim otherwise would be to have not read the CC transcripts or been on any of the CCs.
He said they would be ready pending the FDA. They are probably completing small studies just like Zogenix did for approval. In fact I suspect that those manipulating the stock LOL LOL are well aware of this fact and its significance...Often the market is a transfer of wealth from the impatient to the patient. Unfortunately, it is often from the impatient to the stock manipulator
No it is basically the same precedence. In fact Zohydro goes even further. Zohydro is basically definitive proof that additional efficacy or other trials are very likely not needed. In fact Zohydro basically proved that Elite's ADT drugs are coming much much sooner then later. So what you are posting is misinformation.
That would be true except it is 100% false.
That's very encouraging for Elite. It just gets better and better..
What does Elite need? About $10m for every double in stock price? Any attempts to say Elite is not going to make a ton of revenue and earnings is not using normal math. Market in AJ report is 10 Billion dollars....
1% of that is $100m
Exactly. That really is the elephant in the room. People can talk about a bunch of manipulators posting comments on a SA article but the reality is we are seeing the path for pretty rapid approval of Elite's pipeline through the latest approvals.
Actual investors have their eyes on that key piece of data because things are looking like a very rapid appreciation in Elite value.
I don't know about desperate. It certainly means they are not worried about companys adding inactive ingredients in capsule formulations.
SO what we have learned today is that the FDA has approved an ADT formulation without efficacy or safety or Ph3 as so many claimed was required.
A capsule formulation at that....and the is truly LOL LOL
Bodes incredibly well for Elite.
If by bad news, you mean great news then it would make sense. But basically it seems Elite and Camargo likely knew what they were doing....
Seems Zogenix ADT version was approved without additional trials. Certainly not efficacy or PH3. I would say this supports the idea that Elite will not need these big trials that some have been yelling about.
Targin works for ADT but was originally developed to help for both pain and the associated constipation that sometimes comes with using Opioids.
Naloxone is fast acting and short lived. Used for treating overdose in ER but I don't think it stops people from crushing the drug in their mouth and abusing that way. Because it is short lived and fast acting the effects are more severe when abused. Naltrexone is much more subtle, last long without as severe an effect...and works orally.
Want to hear something funny? Elite could easily create a Targin that actually solved all three problems. One bead Naltrexone, One bead slowly leaked Naloxone for constipation and the opioid bead....But the ADT effect of Naloxone is problematic
You can't really tell real short volume vs what is one hand washing the other with the MMs.
It does seem that you can simply crush it in your mouth...Wonder why the Oxymorphone drug didnt get labeling...
A year?...two weeks actually....but why split hairs.
And the Epic info you just noted....I am pretty sure that is completely wrong. Can you tell me the products, market size and # of competitors on those....tia
Seems you can crush them in your mouth too in order to does dump and break the ER
Interesting. Maybe it will be a good product and effective ADT for their product. Won't find out until much later this year. Not sure how it matters to Elite though.
oh. Yeah me too. I will sell all my shares immediately. Thanks goodness I saw that...oh wait a second...why do I care again?
Sure I would rather there be 60m shares and a $2.50 stock price and have it trade on Nasdaq to bring institutional investing but the cap is otherwise the same. So if the point is to stop the constant manipulation by shorts and others...I would agree